四逆散加味对肝纤维化大鼠肝组织中TGF-β1及其受体基因和蛋白表达的影响  被引量:5

Effect of SiniSan Jiawei on TGF-β_1 and its Receptor Gene and Protein Expression in Liver Tissue of Rats with Hepatic Fibrosis

在线阅读下载全文

作  者:王剑锋[1] 王付[2] 苗小玲[2] 尚立芝[2] 

机构地区:[1]南京中医药大学基础医学院,南京210023 [2]河南中医学院基础医学院,郑州450008

出  处:《中国实验方剂学杂志》2013年第20期176-180,共5页Chinese Journal of Experimental Traditional Medical Formulae

基  金:河南省科学技术厅科技攻关项目(0424420047);郑州市科技领军人才项目(112PLJRC360)

摘  要:目的:探讨四逆散加味治疗肝纤维化的疗效及其作用机制。方法:将80只Wister大鼠随机分为正常组,模型组,四逆散组(4.0 g·kg-1),四逆散加味高、中、低剂量组(依次为14,7,3.5 g·kg-1),四逆散加味预防组(7 g·kg-1),秋水仙碱组(0.2 mg·kg-1),除正常组外,其余各组均采用猪血清ip诱发肝纤维化每周2次,每次0.5 mL/只,连续10周。采用反转录-聚合酶反应(RT-PCR)和链霉菌抗生物素蛋白-过氧化物酶连结法(S-P)检测肝组织转化生长因子β1(TGF-β1)及其受体基因和蛋白表达。结果:与正常组比较,模型组大鼠肝组织中TGF-β1及其受体基因和蛋白大量表达(P<0.01);经四逆散加味治疗后与模型组比较,大鼠肝组织中TGF-β1及其受体基因和蛋白表达量显著下调(P<0.01);与秋水仙碱组比较,四逆散加味中剂量组、四逆散加味预防组TGF-β1及其受体基因和蛋白表达下调更为显著(P<0.01)。结论:四逆散加味治疗肝纤维化的可能作用机制是通过减少肝组织中TGF-β1的产生及下调转化生长因子受体(TGFR)表达而减少肝星状细胞活化,减少肝组织中细胞外基质(ECM)的生成,而起到抗肝纤维化和保护肝细胞损伤的作用。Objective:To discuss the curative effect and action mechanism of Sinisan Jiawei flavored in treatment of hepatic fibrosis.Method:Eighty Wister rats were randomly divided into eight groups:normal group;model group; Sinisan group (4.0 g ·kg-1) ; high dose group,mediate dose group and low dose group (14,7,3.5 g ·kg-1) and prevention group (7 g ·kg-1) of supplemental Sinisan; colchicine group (0.2 mg ·kg-1).Except the norrmal groups,all the other groups were given pig serum to induce liver fibrosis twice a week,0.5 mL/per rat for 10 weeks.By RT-PCR and immunohistochemical S-P method were used to monitor liver tissue transforming growth factor β1 (TGF-β1) and its receptor gene and protein expression.Result:After treatment of Sinisan Jiawei flavored the rats liver tissue TGF beta 1 and its receptor gene and protein expression significantly lower (P <0.01) compared with the model group compared.Compared with colchicine group,the TGF-β1 and its receptor gene and protein expression lowered more significantly (P <0.01).Conclusion:The action mechanism of Sinisan Jiawei flavored in treatment of hepatic fibrosis may reduce liver tissue TGF-β1 and TGFR expression.

关 键 词:四逆散加味 肝纤维化 转化生长因子 

分 类 号:R285.5[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象